Hepatitis C Virus
Studies from Canada and Japan describe new findings in hepatitis C virus research
Published in Hepatitis Weekly, February 26th, 2007
Study 1: New research, "Initiation of protein synthesis by hepatitis C virus is refractory to reduced eIF2.GTP.Met-tRNAiMet ternary complex availability," is the subject of a report. According to recent research published in the journal Molecular Biology of the Cell, "A cornerstone of the antiviral interferon response is phosphorylation of eukaryotic initiation factor (eIF)2alpha. This limits the availability of eIF2.GTP.Met-tRNA(i)(Met) ternary complexes, reduces formation of 43S preinitiation complexes, and blocks viral (and most cellular) mRNA translation."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-02-26)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
Biolex Therapeutics initiates phase IIa trial of Locteron in hepatitis C - Hepatitis C Virus
Chugai gets approval for antiviral agent Copegus to treat hepatitis - Hepatitic B Vaccines
New findings in hepatitic b vaccines described from University of New Mexico, College of Pharmacy - Hepatitis A Virus Risk Factors
Researchers from University of Hamburg, Center for Interdisciplinary Addiction Research report on findings in hepatitis A virus risk factors - Hepatitis A Virus Vaccines
Research on hepatitis A virus vaccines described by scientists at Centers for Disease Control and Prevention - Hepatitis A Virus Vaccines
Studies from King Fahad National Guard Hospital describe new findings in hepatitis A virus vaccines - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
